Oxymatrine reduces liver fibrosis by limiting the pro-inflammatory cytokines, interleukin-6 and TNF-α generated by carbon tetrachloride and boosting anti-inflammatory factors such as interleukin-10 [139]. Here, IL6 is linked to Hepatic fibrosis.